Subject: RTON Creates New Revenue Stream Seasoned Partner

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
RTON Fills Market Needs with new JV Partner
Hot Stock to WatchHot Stock to Watch

Company: Right On Brands Inc. (OTCQB: RTON)


Price: 0.35

Change (%): - 0.02 (5.41)

Volume: 41,067
RTON Chart

Right On Brands (RTON) Forms Joint Venture To Launch ENDO Labs

LOS ANGELES, CA, April 16, 2018 (GLOBE NEWSWIRE) -- Right On Brands, Inc.™ (OTCQB: RTON) announced today that the company has formed a joint venture with Minnesota based Centre Manufacturing, LLC to create ENDO Labs.

ENDO Labs was created to fill the void in the hemp derived CBD marketplace for the creation and manufacturing of quality formulated CBD products. Right On Brands will have 51% ownership of the joint venture with Ashok Patel's Centre Manufacturing, LLC. The new company will develop, manufacture and produce "white label" products for other companies seeking to retail cannabis based products under their own label. ENDO labs has the ability to formulate food, beverage, skin-care/topical, supplements, pet, and can take on advanced formulations and products to any customers preference. ENDO Labs will also have the function of brokering CBD oil for its customers, and clients. This will be the turn key solution to bring in quality CBD products to life.

Centre Manufacturing LLC has manufactured numerous products over the years for companies around the world that strive to provide the highest quality, all-natural products to their customers, both human and animal. Dr. Patel has used his expertise in medical biochemistry to formulate products that are safe and effective, as well as provide the benefits of the latest breakthroughs in science.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks